Vident Investment Advisory’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-146,807
| Closed | -$74.8K | – | 1247 |
|
|
2022
Q4 | $74.8K | Buy |
146,807
+1,375
| +0.9% | +$700 | ﹤0.01% | 1125 |
|
|
2022
Q3 | $149K | Buy |
145,432
+9,579
| +7% | +$9.81K | ﹤0.01% | 1037 |
|
|
2022
Q2 | $178K | Buy |
135,853
+9,696
| +8% | +$12.7K | 0.01% | 1150 |
|
|
2022
Q1 | $195K | Buy |
126,157
+73,512
| +140% | +$114K | 0.01% | 1195 |
|
|
2021
Q4 | $97K | Buy |
52,645
+2,079
| +4% | +$3.83K | ﹤0.01% | 1180 |
|
|
2021
Q3 | $208K | Buy |
+50,566
| New | +$208K | 0.01% | 1080 |
|